2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   7

Issue No. :  11

Year :  2014

Pages :   1311-1314

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Allready Registrered
Click to Login

Oral Rhabdomyosarcoma

Address:   P.S. Subiksha
Saveetha Dental College, Chennai-77
*Corresponding Author
DOI No: Not Available

Rhabdomyosarcoma (RMS) is a malignant soft tissue neoplasm consisting of cells derived from the primitive mesenchyme that exhibit a profound tendency to myogenesis. About 35% of RMS arises in the head and neck,it is less frequent in oral cavity. These are the most common soft tissue sarcoma of the children, adolescents and young adults. Their etiopathogenesis and its molecular relevance have been emphasized. The first line of treatment is radical excision and this is usually supplemented by radiotherapy. It is believed that adjunct combination chemotherapy may greatly improve the prognosis. Inadequately treated tumours grow in an infiltrative manner and recur in a high percentage of cases. Bone does not constitute an effective barrier to the growth of the tumour and bone invasion is a frequent finding in head and neck rhabdomyosarcomas.
Rhabdomyosarcoma, botryoid, sarcomas, undifferentiated.
P.S. Subiksha. Oral Rhabdomyosarcoma. Research J. Pharm. and Tech. 7(11): Nov. 2014 Page 1311-1314.
[View HTML]      [View PDF]

Visitor's No. :   660371